LivaNova (LIVN) Other Non-Current Assets (2015 - 2026)
LivaNova (LIVN) reported Other Non-Current Assets of $15.4 million for Q1 2026, up 10.7% on a YoY basis from $13.9 million in Q1 2025, and down 2.05% sequentially from $15.7 million in Q4 2025.
LivaNova (LIVN) Other Non-Current Assets (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Other Non-Current Assets data on file, last reported at $15.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 10.7% year-over-year to $15.4 million; the trailing twelve-month figure through Mar 2026 stood at $15.4 million (up 10.7% YoY), and the FY2025 full-year result was $15.7 million, up 11.02% from the prior year.
- Other Non-Current Assets retreated to $15.4 million in Q1 2026, from $15.7 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $17.9 million in Q1 2022 to a low of $12.1 million in Q4 2023.
- A 5-year average of $14.7 million and a median of $14.4 million in 2024 frame the typical range for Other Non-Current Assets.
- Peak annual rise in Other Non-Current Assets reached 23.88% in 2022, while the deepest fall reached 73.44% in 2022.
- Tracing LIVN's Other Non-Current Assets over 5 years: stood at $16.2 million in 2022, then retreated by 25.68% to $12.1 million in 2023, then rose by 17.15% to $14.1 million in 2024, then increased by 11.02% to $15.7 million in 2025, then slipped by 2.05% to $15.4 million in 2026.
- Business Quant data shows LIVN's Other Non-Current Assets at $15.4 million in Q1 2026, $15.7 million in Q4 2025, and $14.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.59 Bn | 176.29 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.07 Bn | 126.19 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 108.58 Bn | 99.36 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 68.64 Bn | 67.19 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 48.38 Bn | 44.71 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 285.90 Mn |
| 7 | GE HealthCare Technologies | 28.13 Bn | 25.84 Bn | 1.98 Bn | 2.25 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | 164.00 Mn |
| 9 | Koninklijke Philips | 24.27 Bn | 21.15 Bn | 2.07 Bn | 828.89 Mn |
| 10 | LivaNova | 4.38 Bn | 3.84 Bn | 243.75 Mn | 15.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.37 Mn |
| Dec 31, 2025 | 15.69 Mn |
| Sep 30, 2025 | 14.80 Mn |
| Jun 30, 2025 | 14.33 Mn |
| Mar 31, 2025 | 13.88 Mn |
| Dec 31, 2024 | 14.13 Mn |
| Sep 30, 2024 | 14.37 Mn |
| Jun 30, 2024 | 14.36 Mn |
| Mar 31, 2024 | 13.37 Mn |
| Dec 31, 2023 | 12.06 Mn |
| Sep 30, 2023 | 12.12 Mn |
| Jun 30, 2023 | 13.48 Mn |
| Mar 31, 2023 | 13.95 Mn |
| Dec 31, 2022 | 16.23 Mn |
| Sep 30, 2022 | 16.54 Mn |
| Jun 30, 2022 | 17.14 Mn |
| Mar 31, 2022 | 17.92 Mn |
| Dec 31, 2021 | 13.10 Mn |
| Sep 30, 2021 | 25.41 Mn |
| Jun 30, 2021 | 25.50 Mn |